-
New anti-inflammatory drugs! Stellara, an IL-12 / 23 inhibitor of Johnson & Johnson, has been approved by the European Union to treat pediatric patients with plaque psoriasis aged 6-11 years!
Time of Update: 2020-01-24
January 24, 2020 / bioun / -- Janssen Pharmaceutical, a subsidiary of JNJ, recently announced that the European Commission (EC) has approved to expand the use of stellara (Chinese trade name: sidano,
-
JAMA network open: why do antibiotics affect childhood obesity?
Time of Update: 2020-01-24
January 24, 2020 / bioin / - children who receive multiple antibiotic prescriptions early in life may be prone to obesity, according to new research In the first study, the researchers found that four
-
We underestimate the severity of pneumonia
Time of Update: 2020-01-24
January 22, 2020 / BIOON / -- recently, a young patient named Dakota Allen spent six hours in the emergency room of St Luke's hospital He had been coughing for weeks before, but he never took it serio
-
SCI trans Med: antiviral therapy helps to develop anticancer drugs
Time of Update: 2020-01-24
January 24, 2020 / Biovalley / for many years, Jeffrey Glenn, a virologist at Stanford University, has been trying to develop new ways to fight viruses that cause hepatitis and the common cold; but th
-
Diagnosis of viral pneumonia in Wuhan around the world
Time of Update: 2020-01-24
January 24, 2020 / BIOON / -- since its appearance on December 31, the SARS like virus in Wuhan has spread to a certain extent The following is a list of countries and regions that have so far identif
-
SCI trans Med: skin lotion can prevent mosquito borne diseases
Time of Update: 2020-01-24
January 24, 2020 / Biovalley / a new study from the University of Leeds shows that a skin cream used to treat warts and skin cancer can help people prevent viral diseases such as Zika virus and dengue
-
Weigh! Two pieces of nature reveal new strategies to reverse HIV latency
Time of Update: 2020-01-23
January 23, 2020 / Biovalley BIOON / - -- about 38 million people around the world are infected with HIV, and about 1.1 million people in the United States are infected with the virus Currently, peopl
-
Turn "cold tumor" into "hot tumor"! Modixafortide, a new CXCR4 antagonist of bilinerx, has a strong therapeutic effect on pancreatic cancer
Time of Update: 2020-01-23
January 23, 2020 / Biovalley biolon / -- biolinerx is a clinical stage biopharmaceutical company focusing on the development of innovative oncology drugs Recently, the company announced that the tripl
-
Jaci: rare genetic variation affecting severe infection
Time of Update: 2020-01-23
January 22, 2020 / bioun / -- chronic granulomatous disease (CGD) is a rare genetic disease, affecting one in 210000 people worldwide, and usually occurs when young Recently, researchers at the Univer
-
J affect dis: Despite antiretroviral treatment, HIV patients still lose immunity to smallpox
Time of Update: 2020-01-23
January 23, 2020 / Biovalley BIOON / - -- in a new study, researchers from the University of health and Science in Oregon and the National Primate Research Center in Oregon reported that HIV patients
-
Systemic lupus erythematosus (SLE) new drug! AstraZeneca type I interferon receptor targeting mAb anifrolumab key phase III clinical success!
Time of Update: 2020-01-23
January 23, 2020 / BIOON / -- recently, the results of the tulip 2 study (nct02446899) on the key phase III of AstraZeneca in the treatment of systemic lupus erythematosus (SLE) were published in the
-
Nat commun: blocking Siah 2 enhances the antitumor immune response of PD-1 inhibitors
Time of Update: 2020-01-23
January 23, 2020 / BIOON / - -- in a new study, researchers from the Sanford Burnham prebys medical discovery Institute and the New York University School of Medicine found a new way to improve the im
-
January 17, 2020 Science journal essence
Time of Update: 2020-01-22
January 20, 2020 / BIOON / - -- a new issue of Science Journal (January 17, 2020) is published this week What are the highlights of its research? Let Xiaobian come together The picture is from science
-
Exercise may be a good medicine for the common cold
Time of Update: 2020-01-22
January 22, 2020 / BIOON / -- according to health experts, exercise may play an unexpected role in fighting colds Dr Jayson loeffert, a sports medicine doctor at Penn State Health in Hershey, Pa., sai
-
How can scientists target stem cells to treat multiple human cancers?
Time of Update: 2020-01-22
In this paper, I have compiled several research reports to jointly interpret how scientists can treat a variety of human cancers by targeting stem cells, and learn with you! Photo source: NIH [1] NAT
-
The first treatment for thyroid ophthalmopathy! Horizon's IGF-1R targeted monoclonal antibody tepezza (teprotumumab) has been approved by the US FDA!
Time of Update: 2020-01-22
January 22, 2020 / BIOON / -- horizon Pharma is a pharmaceutical company focusing on the development and commercialization of innovative drugs to meet the treatment needs of rare and rheumatic disease
-
Many articles interpret the new achievements of blood-brain barrier research!
Time of Update: 2020-01-22
In this paper, I have compiled many research results, and jointly interpreted the new achievements of scientists in the field of blood-brain barrier research, and shared them with you! Source: Daniel
-
PLoS patching: how diarrhea pathogens affect body temperature
Time of Update: 2020-01-22
January 21, 2020 / BIOON / -- many bacterial pathogens will discharge toxins immediately after entering the host to inhibit its immune response Recently, researchers at the University of rub in Bochum
-
JACM: how to prevent and treat food allergy by breastfeeding
Time of Update: 2020-01-22
January 21, 2020 / Biovalley / according to the latest research by researchers from the University of Western Australia, breastfeeding mothers may need to eat more eggs to prevent babies from being al
-
Science subjournal: the understanding of PD-1 has encountered a turning point! Targeted removal of PD-1 from myeloid cells can induce antitumor immune response
Time of Update: 2020-01-21
January 21, 2020 / Biovalley BIOON / - -- as a T-cell checkpoint receptor, PD-1 is the main factor that inhibits T-cell response expressed on the surface of activated T cells, and therefore is the tar
